Financials
Schedule 13D/G History
Insiders
Holders
Other Reports

Sarepta Therapeutics, Inc. - Significant Ownership

Signature - Title: Sarepta Therapeutics, Inc. - Ian Estepan, Executive Vice President, Chief Financial Officer
Location: Cambridge, MA
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Sarepta Therapeutics, Inc..

Significant Ownership of Sarepta Therapeutics, Inc.

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
ARWR	ARROWHEAD PHARMACEUTICALS, INC.	Common stock, par value $0.001 per share (the "Common Stock")	9.5%	$180M		11.9M		Sarepta Therapeutics, Inc.	Feb 7, 2025

Showing 1 to 1 of 1 entries

Schedules 13D/G Reported by Sarepta Therapeutics, Inc.:

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.